Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma

Cancer Letters

Volumn 323, Issue 2, 2012, Pages 147-154

  Mo, Yingxi ^a   Midorikawa, Kaoru ^a   Zhang, Zhe ^b   Zhou, Xiaoying ^b   Ma, Ning ^c   Huang, Guangwu ^b   Hiraku, Yusuke ^a   Oikawa, Shinji ^a   Murata, Mariko ^a  

^a MIE UNIVERSITY   (Japan)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Methylation; Nasopharyngeal carcinoma; RRAD

Indexed keywords

DNA; GUANOSINE TRIPHOSPHATASE; RAS RELATED ASSOCIATED WITH DIABETES; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; MALE; NASAL BIOPSY; NASOPHARYNX CARCINOMA; NOSE MUCOSA; PRIORITY JOURNAL; PROMOTER REGION; RRAD GENE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BIOPSY; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; GENES, TUMOR SUPPRESSOR; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; RAS PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84863100689     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.03.042     Document Type: Article

References (25)

1. Tao Q., Chan A.T. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev. Mol. Med. 2007, 9:1-24.
2. Yu M.C., Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 2002, 12:421-429.
3. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 2002, 12:431-441.
4. Z. Zhang, D. Sun, N. Van do, A. Tang, L. Hu, G. Huang, Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma, Int. J. Cancer 120 (2007) 32-38.
5. D. Sun, Z. Zhang, N. Van do, G. Huang, I. Ernberg, L. Hu, Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker, Oral Oncol. 43 (2007) 82-87.
6. Ying J., Li H., Seng T.J., Langford C., Srivastava G., Tsao S.W., Putti T., Murray P., Chan A.T., Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006, 25:1070-1080.
7. Li L., Tao Q., Jin H., van Hasselt A., Poon F.F., Wang X., Zeng M.S., Jia W.H., Zeng Y.X., Chan A.T., Cao Y. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin. Cancer Res. 2010, 16:2949-2958.
8. Lo K.W., Huang D.P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 2002, 12:451-462.
9. Reynet C., Kahn C.R. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993, 262:1441-1444.
10. Moyers J.S., Bilan P.J., Reynet C., Kahn C.R. Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. J. Biol. Chem. 1996, 271:23111-23116.
11. Downward J. Regulatory mechanisms for ras proteins. Bioessays 1992, 14:177-184.
12. Tisdale E.J., Bourne J.R., Khosravi-Far R., Der C.J., Balch W.E. GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J. Cell Biol. 1992, 119:749-761.
13. Ridley A.J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
14. Fu M., Zhang J., Tseng Y.H., Cui T., Zhu X., Xiao Y., Mou Y., De Leon H., Chang M.M., Hamamori Y., Kahn C.R., Chen Y.E. Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration. Circulation 2005, 111:1071-1077.
15. Olek A., Oswald J., Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucl. Acids Res. 1996, 24:5064-5066.
16. Tseng Y.H., Vicent D., Zhu J., Niu Y., Adeyinka A., Moyers J.S., Watson P.H., Kahn C.R. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Cancer Res. 2001, 61:2071-2079.
17. Lee I., Yeom S.Y., Lee S.J., Kang W.K., Park C. A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment. Cancer Res. 2010, 70:4357-4365.
18. Suzuki M., Toyooka S., Shivapurkar N., Shigematsu H., Miyajima K., Takahashi T., Stastny V., Zern A.L., Fujisawa T., Pass H.I., Carbone M., Gazdar A.F. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 2005, 24:1302-1308.
19. Suzuki M., Shigematsu H., Shames D.S., Sunaga N., Takahashi T., Shivapurkar N., Iizasa T., Minna J.D., Fujisawa T., Gazdar A.F. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Ann. Surg. Oncol. 2007, 14:1397-1404.
20. Suzuki M., Shigematsu H., Shivapurkar N., Reddy J., Miyajima K., Takahashi T., Gazdar A.F., Frenkel E.P. Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. Cancer Lett. 2006, 242:222-230.
21. Sova P., Feng Q., Geiss G., Wood T., Strauss R., Rudolf V., Lieber A., Kiviat N. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol. Biomark. Prev. 2006, 15:114-123.
22. Hsiao B.Y., Chen C.C., Hsieh P.C., Chang T.K., Yeh Y.C., Wu Y.C., Hsu H.S., Wang F.F., Chou T.Y. Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells. J. Mol. Med. (Berl.) 2011, 89:481-492.
23. Zhu J., Reynet C., Caldwell J.S., Kahn C.R. Characterization of Rad, a new member of Ras/GTPase superfamily, and its regulation by a unique GTPase-activating protein (GAP)-like activity. J. Biol. Chem. 1995, 270:4805-4812.
24. Agaoglu F.Y., Dizdar Y., Dogan O., Alatli C., Ayan I., Savci N., Tas S., Dalay N., Altun M. P53 overexpression in nasopharyngeal carcinoma. In Vivo 2004, 18:555-560.
25. Rubio L., Burgos J.S., Lopez-Guerrero J.A., Morera C., Vera-Sempere F.J. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients. Pathol. Res. Pract. 2002, 198:97-102.